US2016222365A1PendingUtilityA1
Alpha-amylase mutants
Est. expiryOct 30, 2017(expired)· nominal 20-yr term from priority
Inventors:Torben Vedel BorchertAllan SvendsenCarsten AndersenBjarne Ronfeldt NielsenTorben Lauesgaard NissenSoren Kjaerulff
C12N 9/2417C11D 3/38609C07K 14/32C11D 3/38636C12Y 302/01001C11D 3/386
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a variant of a parent Termamyl-like α-amylase, which exhibits an alteration in at least one of the following properties relative to said parent α-amylase: i) improved pH stability at a pH from 8 to 10.5; and/or ii) improved Ca 2+ stability at pH 8 to 10.5, and/or iii) increased specific activity at temperatures from 10 to 60° C.
Claims
exact text as granted — not AI-modified1 . A variant alpha-amylase of a parent alpha-amylase, wherein the variant has alpha-amylase activity, and at least 95% homology with the amino acid sequence shown in SEQ ID. NO. 3 comprising one or more of the following substitutions (using SEQ ID NO: 3 for numbering):
I181A,R,N,C,E,Q,G,H,L,K,M,F,P,S,T,W,Y, or V, wherein the variant has increased specific activity relative to the parent alpha-amylase, wherein specific activity is determined at a temperature of 10° C. to 60° C.
2 . The variant of claim 1 , wherein the variant comprises a substitution of I181A.
3 . The variant of claim 1 , wherein the variant comprises a substitution of I181R.
4 . The variant of claim 1 , wherein the variant comprises a substitution of I181N.
5 . The variant of claim 1 , wherein the variant comprises a substitution of I181C.
6 . The variant of claim 1 , wherein the variant comprises a substitution of I181E.
7 . The variant of claim 1 , wherein the variant comprises a substitution of I181Q.
8 . The variant of claim 1 , wherein the variant comprises a substitution of I181G.
9 . The variant of claim 1 , wherein the variant comprises a substitution of I181H.
10 . The variant of claim 1 , wherein the variant comprises a substitution of I181L.
11 . The variant of claim 1 , wherein the variant comprises a substitution of I181K.
12 . The variant of claim 1 , wherein the variant comprises a substitution of I181M.
13 . The variant of claim 1 , wherein the variant comprises a substitution of I181F.
14 . The variant of claim 1 , wherein the variant comprises a substitution of I181P.
15 . The variant of claim 1 , wherein the variant comprises a substitution of I181S.
16 . The variant of claim 1 , wherein the variant comprises a substitution of I181T.
17 . The variant of claim 1 , wherein the variant comprises a substitution of I181W.
18 . The variant of claim 1 , wherein the variant comprises a substitution of I181Y.
19 . The variant of claim 1 , wherein the variant comprises a substitution of I181V.
20 . A variant alpha-amylase of a parent alpha-amylase, which variant has alpha-amylase activity and at least 95% homology with the amino acid sequence shown in SEQ ID. NO. 3, comprising a substitution (using SEQ ID NO: 3 for numbering):
at position 181, wherein the variant has increased specific activity relative to the parent alpha-amylase, wherein the specific activity is determined at a temperature of 20° C. to 50° C.Join the waitlist — get patent alerts
Track US2016222365A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.